V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260016825 | 260009616 | 1.56 | 93.7 | Neo-adjuvant (N) | null | 2017-12-14 | NIVOLUMAB | N | N | 260029046 | DOCETAXEL + TRASTUZUMAB |
| 260016826 | 260009617 | null | 61.2 | Curative (C) | 2015-08-16 | 2015-09-01 | OSIMERTINIB | 2 | N | 260029047 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260016828 | 260009622 | 1.78 | 126.5 | Neo-adjuvant (N) | 2018-07-13 | 2018-07-14 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 260029065 | CARBO + THIOTEPA + TOPOTECAN |
| 260016829 | 260018789 | 1.64 | 67.8 | Curative (C) | 2018-03-22 | 2018-05-17 | Gemcitabine + Oxaliplatin | 2 | N | 260029067 | BLEOMYCIN + VINCRISTINE |
| 260016830 | 260009627 | null | null | null | 2017-09-24 | 2017-09-28 | BLEOMYCIN | 02 | N | 260029076 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260016831 | 260009630 | 1.78 | 91.9 | Curative (C) | 2018-06-08 | 2018-06-08 | ECX | N | N | 260029080 | CARBO + THIOTEPA + TOPOTECAN |
| 260016832 | 260009634 | null | 60.9 | null | 2016-08-04 | 2016-08-15 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | null | 260029096 | CYCLOPHOSPHAMIDE |
| 260016833 | 260009636 | 1.66 | 59 | Palliative (P) | 2015-10-22 | 2015-10-22 | IFOSFAMIDE + PACLITAXEL | N | N | 260029097 | BLEOMYCIN |
| 260016834 | 260009637 | 1.64 | 78.9 | Palliative (P) | 2016-03-27 | 2017-11-20 | BLEOMYCIN + VINCRISTINE | N | N | 260029099 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260016835 | 260009640 | null | 59.6 | Curative (C) | 2015-12-10 | 2016-01-07 | Cisplatin + Radiotherapy | 02 | N | 260029116 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260016836 | 260014589 | 1.62 | 68 | Palliative (P) | 2016-08-04 | 2016-08-08 | CVP | N | N | 260029129 | TRASTUZUMAB |
| 260016837 | 260009645 | null | 63.7 | null | 2017-05-31 | 2017-06-01 | CVP | N | N | 260029135 | ICE |
| 260016838 | 260014590 | null | null | Palliative (P) | 2018-10-16 | 2018-11-16 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | null | 260029137 | POMB |
| 260016839 | 260009653 | 1.65 | 72.9 | Curative (C) | 2015-11-10 | 2015-12-09 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260029145 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260016840 | 260014591 | 1.7 | 94.5 | Disease modification (D) | 2017-09-03 | 2017-09-09 | Pemetrexed | 2 | N | 260029157 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260016841 | 260009658 | 1.67 | 70 | Disease modification (D) | 2017-04-08 | 2017-04-08 | Docetaxel | 02 | N | 260029168 | METHOTREXATE HIGH DOSE |
| 260016842 | 260009660 | 1.7 | 101 | null | 2017-09-04 | 2017-09-04 | BLEOMYCIN | N | null | 260029169 | BLEOMYCIN |
| 260016843 | 260009662 | 1.79 | null | Curative (C) | null | 2016-09-23 | POMB/ACE | 02 | N | 260029185 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL |
| 260016844 | 260014593 | null | 71.1 | Curative (C) | null | 2014-12-10 | IFOSFAMIDE + PACLITAXEL | Y | null | 260029191 | CISPLATIN + GEMCITABINE |
| 260016845 | 260014594 | 1.79 | 72 | Curative (C) | 2018-02-19 | 2018-02-27 | CISPLATIN + EPIRUBICIN | 2 | N | 260029198 | IPO |
| 260016846 | 260009665 | 1.81 | 80.6 | Disease modification (D) | 2013-07-05 | 2014-12-19 | PAC-PLAT | 02 | N | 260029201 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260016847 | 260009666 | 1.82 | 88.8 | Disease modification (D) | 2018-03-17 | 2018-07-22 | Docetaxel + Gemcitabine with GCSF | N | N | 260029207 | POMB |
| 260016848 | 260009671 | 0 | 106.2 | Neo-adjuvant (N) | 2014-01-27 | 2014-02-07 | EP | N | N | 260029219 | CYTARABINE + METHOTREXATE HD |
| 260016849 | 260009671 | null | 69 | Curative (C) | null | 2017-05-11 | IBRUTINIB | 2 | N | 260029219 | DOCETAXEL |
| 260016850 | 260009674 | null | null | Disease modification (D) | null | 2014-04-13 | GEMCITABINE + TIP | null | null | 260029231 | ICE |
| 260016851 | 260014601 | 1.88 | 91.1 | Palliative (P) | 2017-08-16 | 2017-08-16 | BLEOMYCIN | N | N | 260029236 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260016852 | 260009678 | 1.65 | 84.6 | Curative (C) | 2016-11-24 | 2016-11-27 | VIP | N | N | 260029241 | CARBOPLATIN + EPIRUBICIN + ETOPOSIDE + MELPHALAN |
| 260016853 | 260009684 | 1.65 | 53.8 | Not known (9) | 2017-06-14 | 2017-07-13 | ACE (germ cell) | N | N | 260029247 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260016854 | 260009686 | 1.81 | null | null | 2018-09-09 | 2018-09-12 | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + MITOXANTRONE + VINCRISTINE | N | Y | 260029256 | IVE-R |
| 260016855 | 260009687 | 1.78 | 81 | Disease modification (D) | 2019-01-09 | 2019-02-01 | Cisplatin + Vinorelbine (IV) | N | N | 260029259 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260016856 | 260009689 | 1.73 | 89 | Adjuvant (A) | null | 2017-04-30 | GEMCITABINE + TIP | null | N | 260029265 | BLEOMYCIN + VINCRISTINE |
| 260016857 | 260009690 | 1.76 | 87.4 | Curative (C) | 2018-02-18 | 2018-02-18 | Cisplatin | 02 | N | 260029266 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL |
| 260016858 | 260009690 | 1.81 | 76.7 | Palliative (P) | 2018-07-23 | 2018-07-29 | GEMCITABINE + TIP | N | N | 260029266 | BLEOMYCIN |
| 260016859 | 260009691 | 1.75 | 63 | Palliative (P) | 2018-06-09 | 2018-07-29 | Cyclophosphamide High Dose | N | N | 260029288 | RMS 2005 TRIAL |
| 260016860 | 260014607 | null | null | Curative (C) | 2017-01-01 | 2017-03-27 | ICE | N | N | 260029297 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260016861 | 260014608 | 1.54 | 61.8 | Palliative (P) | 2018-07-10 | 2018-07-13 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | N | 260029313 | BENDAMUSTINE + OBINUTUZUMAB |
| 260016862 | 260009696 | 1.89 | 86 | Palliative (P) | 2016-09-02 | 2016-09-02 | ACE (germ cell) | 2 | N | 260029321 | GEMCITABINE + OXALIPLATIN |
| 260016863 | 260009699 | 1.87 | 91.5 | Disease modification (D) | 2018-07-12 | 2018-07-17 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260029330 | VIP |
| 260016864 | 260009700 | 1.72 | 83.3 | Curative (C) | 2015-05-22 | 2015-06-10 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260029334 | IVA |
| 260016865 | 260009701 | 1.75 | 67.3 | Palliative (P) | 2018-05-02 | 2018-05-04 | CISPLATIN + METHOTREXATE + VINCRISTINE | 02 | N | 260029335 | IFOSFAMIDE + PACLITAXEL |
| 260016866 | 260009701 | 1.72 | 69.8 | null | 2014-12-18 | 2014-12-23 | Pemetrexed | N | N | 260029335 | CARBOPLATIN + ETOPOSIDE |
| 260016867 | 260014611 | 1.6 | 46.2 | null | 2014-01-10 | 2014-01-11 | Cyclophosphamide High Dose | N | N | 260029342 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260016868 | 260009704 | 1.75 | 102.4 | Curative (C) | 2014-06-28 | 2014-06-28 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260029348 | GEMCARBO |
| 260016869 | 260009707 | null | null | Palliative (P) | null | 2016-09-13 | Bleomycin + Cisplatin + Vinblastine | null | null | 260029356 | POMB |
| 260016870 | 260009710 | null | 103 | Disease modification (D) | 2015-01-18 | 2015-06-15 | ICE + GCSF | 02 | N | 260029361 | OSIMERTINIB |
| 260016871 | 260009712 | null | 49.25 | Palliative (P) | 2016-12-22 | 2016-12-24 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | null | 260029366 | POMB |
| 260016872 | 260009713 | 1.75 | 101 | Curative (C) | 2019-08-11 | 2019-09-10 | ACE (germ cell) | N | N | 260029368 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260016873 | 260009714 | 1.66 | 110 | Curative (C) | 2017-12-07 | 2017-12-27 | FEC 60 or 75 | N | N | 260029371 | AXITINIB |
| 260016874 | 260009718 | null | null | Palliative (P) | 2017-09-22 | 2017-10-20 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029384 | ECX |
| 260016875 | 260014620 | 1.77 | 72 | Adjuvant (A) | 2015-11-20 | 2015-12-12 | Temozolomide 200mg/m2 | null | N | 260029389 | GEMCITABINE + TIP |